Literature DB >> 24170112

Tuberculosis infection in primary Sjögren's syndrome: a nationwide population-based study.

Yu-Sheng Chang1, Chia-Jen Liu, Shou-Ming Ou, Yu-Wen Hu, Tzeng-Ji Chen, Hui-Ting Lee, Chi-Ching Chang, Chung-Tei Chou.   

Abstract

Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease and may complicate with interstitial lung disease. The risk of Mycobacterium tuberculosis (TB) infection in patients with pSS has not been determined. This nationwide population-based study aimed to explore the incidence and risk factors of TB infection in patients with pSS. We identified 4,822 pSS patients from the Taiwan National Health Insurance database and compared the incidence rates of TB infection in these patients with 48,220 randomly selected age-, sex-, and comorbidity-matched subjects without pSS. The Cox proportional hazard model was used to identify risk factors for TB in patients with pSS. The risk of TB was higher in the pSS cohort than in the control cohort with an incidence rate ratio (IRR) of 1.58 (95% confidence interval [95% CI] 1.13-2.18, p = 0.006). The risk factors for TB in the pSS cohort were age ≥60 years (hazard ratio [HR] 3.22, 95% CI 1.78-5.84; p < 0.001), and corticosteroid usage, which had a dose-dependent effect in the pSS patients compared to the nonusers (daily prednisolone dose or equivalent less than 5 mg/day: HR 2.34; p = 0.020, 95% CI 1.14-4.78; 5 mg/day to less than 10 mg/day: HR 4.79, 95% CI 2.15-10.68; p < 0.001; 10 mg/day or more: HR 12.19, 95% CI 4.42-33.63; p < 0.001). Patients with pSS had a higher risk of pulmonary TB in Taiwan, which was related to age ≥60 years and corticosteroid usage.

Entities:  

Mesh:

Year:  2013        PMID: 24170112     DOI: 10.1007/s10067-013-2408-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  24 in total

1.  Fatal tuberculous myositis in an immunocompromised adult with primary Sjögren's syndrome.

Authors:  Chi-Chang Huang; Ming-Fei Liu; Nan-Yao Lee; Chia-Ming Chang; Hsin-Chun Lee; Chi-Jung Wu; Wen-Chien Ko
Journal:  J Formos Med Assoc       Date:  2010-09       Impact factor: 3.282

Review 2.  Genomic and nongenomic effects of glucocorticoids.

Authors:  Cindy Stahn; Frank Buttgereit
Journal:  Nat Clin Pract Rheumatol       Date:  2008-09-02

3.  Antirheumatic drugs and the risk of tuberculosis.

Authors:  Paul Brassard; Abbas Kezouh; Samy Suissa
Journal:  Clin Infect Dis       Date:  2006-08-10       Impact factor: 9.079

Review 4.  Mycobacterium tuberculosis in Taiwan.

Authors:  Po-Ren Hsueh; Yung-Ching Liu; Jen So; Cheng-Yi Liu; Pan-Chyr Yang; Kwen-Tay Luh
Journal:  J Infect       Date:  2005-10-10       Impact factor: 6.072

5.  Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.

Authors:  Mo Yin Mok; Yi Lo; Tak Mao Chan; Woon Sing Wong; Chak Sing Lau
Journal:  J Rheumatol       Date:  2005-04       Impact factor: 4.666

6.  Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population.

Authors:  H A Kim; C D Yoo; H J Baek; E B Lee; C Ahn; J S Han; S Kim; J S Lee; K W Choe; Y W Song
Journal:  Clin Exp Rheumatol       Date:  1998 Jan-Feb       Impact factor: 4.473

Review 7.  Primary Sjögren's syndrome: new clinical and therapeutic concepts.

Authors:  M Ramos-Casals; A G Tzioufas; J Font
Journal:  Ann Rheum Dis       Date:  2004-10-21       Impact factor: 19.103

Review 8.  Lung disease related to collagen vascular disease.

Authors:  David A Lynch
Journal:  J Thorac Imaging       Date:  2009-11       Impact factor: 3.000

9.  [Tuberculosis and systemic diseases: study of 8 Senegalese cases].

Authors:  S Diallo; S Ndongo; A Leye; A Pouye; M M Ka; T M Diop
Journal:  Med Trop (Mars)       Date:  2009-06

10.  Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.

Authors:  Chih-Cheng Lai; Che-Kim Tan; Yu-Tsung Huang; Chien-Hong Chou; Chien-Ching Hung; Pan-Chyr Yang; Kwen-Tay Luh; Po-Ren Hsueh
Journal:  Clin Infect Dis       Date:  2008-10-01       Impact factor: 9.079

View more
  11 in total

1.  Disseminated histoplasmosis in primary Sjögren syndrome: A case report.

Authors:  Jia-Ai Li; Ying-Ying Cheng; Zhi-Tao Cui; Wei Jiang; Wu-Qiong Zhang; Zhong-Hua Du; Bin Gao; Yin-Yin Xie; Hong-Mei Meng
Journal:  World J Clin Cases       Date:  2020-04-06       Impact factor: 1.337

2.  [Rare superinfection in a COVID-19 patient-A chronology].

Authors:  E Gamon; D Tammena; M Wattenberg; T Augenstein
Journal:  Anaesthesist       Date:  2021-08-24       Impact factor: 1.041

3.  Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort Study.

Authors:  Laurence Fardet; Irene Petersen; Irwin Nazareth
Journal:  PLoS Med       Date:  2016-05-24       Impact factor: 11.069

4.  The risk of nontuberculous mycobacterial infection in patients with Sjögren's syndrome: a nationwide, population-based cohort study.

Authors:  Wen-Cheng Chao; Ching-Heng Lin; Tsai-Ling Liao; Yi-Ming Chen; Chiann-Yi Hsu; Jun-Peng Chen; Der-Yuan Chen; Hsin-Hua Chen
Journal:  BMC Infect Dis       Date:  2017-12-28       Impact factor: 3.090

5.  Association between a history of mycobacterial infection and the risk of newly diagnosed Sjögren's syndrome: A nationwide, population-based case-control study.

Authors:  Wen-Cheng Chao; Ching-Heng Lin; Tsai-Ling Liao; Yi-Ming Chen; Der-Yuan Chen; Hsin-Hua Chen
Journal:  PLoS One       Date:  2017-05-09       Impact factor: 3.240

Review 6.  Infection in systemic lupus erythematosus, similarities, and differences with lupus flare.

Authors:  Ju-Yang Jung; Chang-Hee Suh
Journal:  Korean J Intern Med       Date:  2017-04-28       Impact factor: 2.884

7.  Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren's syndrome without disease modifying treatment.

Authors:  Per Nived; Tore Saxne; Pierre Geborek; Thomas Mandl; Lillemor Skattum; Meliha C Kapetanovic
Journal:  BMC Rheumatol       Date:  2018-04-05

8.  Therapeutic issues with, and long-term outcomes of, pulmonary mycobacterial tuberculosis treatment in patients with autoimmune rheumatic diseases.

Authors:  Dong Won Park; Sung Jun Chung; Yoomi Yeo; Tai Sun Park; Hyun Lee; Ji-Yong Moon; Sang-Heon Kim; Tae-Hyung Kim; Ho Joo Yoon; Jang Won Sohn
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

9.  Risk of Shingles in Adults with Primary Sjogren's Syndrome and Treatments: A Nationwide Population-Based Cohort Study.

Authors:  Jen-Yin Chen; Li-Kai Wang; Ping-Hsun Feng; Chin-Chen Chu; Tain-Junn Cheng; Shih-Feng Weng; Su-Zhen Wu; Tsung-Hsueh Lu; Chia-Yu Chang
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

10.  The increased risk of active tuberculosis disease in patients with dermatomyositis - a nationwide retrospective cohort study.

Authors:  Ping-Hsun Wu; Yi-Ting Lin; Yi-Hsin Yang; Yu-Chih Lin; Yi-Ching Lin
Journal:  Sci Rep       Date:  2015-11-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.